एसिट्रेटिन के इंटरैक्शन
हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें एसिट्रेटिन (Soriatane; रेटिनॉइड) के 91 इंटरैक्शन दर्ज हैं: 34 गंभीर, 43 मध्यम, 4 मामूली, और 10 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।
लेबल से लिए गए इंटरैक्शन
गंभीर इंटरैक्शन (34)
Acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids . (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids . (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see WARNINGS: Pseudotumor Cerebri ). (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see WARNINGS: Pseudotumor Cerebri ). (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
Acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids . (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see WARNINGS: Pseudotumor Cerebri ). (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see WARNINGS: Pseudotumor Cerebri ). (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Primary forms of contraception include: tubal ligation, partner’s vasectomy, intrauterine devices, birth control pills, and injectable/implantable/insertable/topical hormonal birth control products. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see WARNINGS: Pseudotumor Cerebri ). (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
Acitretin is contraindicated in cases of hypersensitivity (e.g., angioedema, urticaria) to the preparation (acitretin or excipients) or to other retinoids . (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
Since both acitretin and tetracyclines can cause increased intracranial pressure, their combined use is contraindicated (see WARNINGS: Pseudotumor Cerebri ). (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
An increased risk of hepatitis has been reported to result from combined use of methotrexate and etretinate. (एसिट्रेटिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))
It has not been established if there is a pharmacokinetic interaction between acitretin and combined oral contraceptives. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
For patients with amenorrhea, the second test should be done at least 11 days after the last act of unprotected sexual intercourse (without using 2 effective forms of contraception [birth control] simultaneously). (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
Clinical evidence has shown that concurrent ingestion of acitretin and ethanol has been associated with the formation of etretinate, which has a significantly longer elimination half-life than acitretin. (एसिट्रेटिन लेबल, बॉक्स्ड चेतावनी)
मध्यम इंटरैक्शन (43)
Patients with elevated vitamin A levels may be at increased risk. (आइवाकैफ्टर लेबल, चेतावनियां और सावधानियां)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Patients with elevated vitamin A levels may be at increased risk. (एलेक्साकैफ्टर, टेज़ाकैफ्टर और आइवाकैफ्टर लेबल, चेतावनियां और सावधानियां)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
- ऑर्लिस्टैटमध्यम
The effect of ORLISTAT on the absorption of supplemental vitamin D, vitamin A, and nutritionally-derived vitamin K is not known at this time [see Clinical Pharmacology (12.3) , and Warnings and Precautions (5.1) ] . (ऑर्लिस्टैट लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
- कैल्शियम क्लोराइडमध्यम
Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (कैल्शियम क्लोराइड लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Glyburide: In a trial of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose-lowering effect of glyburide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
मामूली ज़िक्र (4)
- कैल्शियम ग्लूकोनेटमामूली
Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (कैल्शियम ग्लूकोनेट लेबल, दवाओं के इंटरैक्शन)
Other: There appears to be no pharmacokinetic interaction between acitretin and cimetidine, digoxin, or glyburide. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Vitamin A Based on a case report in one patient receiving combination therapy with all-trans-retinoid acid (an acid form of vitamin A) and fluconazole, central nervous system (CNS) related undesirable effects have developed in the form of pseudotumor cerebri, which disappeared after discontinuation of fluconazole treatment. (फ्लुकोनाज़ोल लेबल, दवाओं के इंटरैक्शन)
Other: There appears to be no pharmacokinetic interaction between acitretin and cimetidine, digoxin, or glyburide. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
कोई महत्वपूर्ण इंटरैक्शन नहीं बताया गया (10)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
Investigations into the effect of acitretin on the protein binding of anticoagulants of the coumarin type (warfarin) revealed no interaction. (एसिट्रेटिन लेबल, दवाओं के इंटरैक्शन)
आप जो कुछ भी लेते हैं, उस सबके साथ एसिट्रेटिन को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।
चेकर में खोलेंयह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।